56.doc

Федеральное государственное учреждение наукиГосударственный научный центр

вирусологии и биотехнологии «Вектор»Федеральной службы по надзору

в сфере защиты прав потребителей и благополучия человека

Рассылка «Актуальные вопросы мониторинга за гриппом птиц»№ 29 (87), 6 июля 2009 г.

Ситуация по гриппу А/H1N1

(http://www.who.int/csr/don/h1n1_20090703_1100.png )

Общее количество лабораторно-подтвержденных случаев заболевания людей,

вызванных вирусом гриппа типа А(H1N1), информация о которых была доведена до ВОЗ (по состоянию на 05 час. 00 мин. московского времени 06 июля 2009 г.) – в приложении к рассылке.

Перечень неофициальных переводов документов ВОЗ и CDC (в приложении к рассылке):

Грипп А (H1N1): выученные уроки и готовность, Д-р Маргарет Чен, Генеральный директор Всемирной организации здравоохранения, Программная речь на встрече на высшем уровне по гриппу А (H1N1), 03 июля 2009 г., http :// www . who . int / csr / resources / publications / swineflu / who _ consultation _200 90624_ en . pdf ;

http://www.who.int/csr/resources/publications/swineflu/who_consultation_20090624_en.pdf


http://www.who.int/csr/don/h1n1_20090703_1100.png

http://www.who.int/csr/don/h1n1_20090703_1100.png

Консультация ВОЗ по временному прекращению занятий и ограничению массовых собраний для смягчения влияния эпидемии, вызванной новым гриппом А (H1N1), 3 июля 2009 г., http :// www . who . int / csr / resources / publications / swineflu / who _ consultation _200 90624_ en . pdf ;

Инфекция, вызванная вирусом гриппа А (H1N1), среди медицинского персонала - Соединенные Штаты, апрель-май 2009 г., 19 июня 2009 г., http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5823a2.htm .

Новые документы Роспотребнадзора: Письмо от 02.07.2009 №01/9202-9-32 «О направлении временных

рекомендаций по использованию масок и респираторов», http://www.rospotrebnadzor.ru/documents/letters/4724/;

Письмо от 01.07.2009 №01/9175-9-32 «О направлении еженедельного эпидемиологического вестника ВОЗ о клинической картине инфекционных заболеваний, вызванных новым вирусом гриппа А (H1N1)», http://www.rospotrebnadzor.ru/documents/letters/4634/.

С документами ВОЗ по гриппу А/H1N1 на английском языке можно ознакомиться здесь: http://www.who.int/csr/resources/publications/swineflu/en/index.html С документами ВОЗ по гриппу А/H1N1 на русском языке можно ознакомиться здесь: http://www.who.int/csr/resources/publications/swineflu/ru/index.html С документами Роспотребнадзора по гриппу А/H1N1 можно ознакомиться здесь: http://www.rospotrebnadzor.ru/documents/letters/2778/С последним номером EISS - Еженедельного электронного бюллетеня Европейской системы надзора за гриппом (EISS) - можно ознакомиться здесь: http://www.eiss.org/cgi-files/bulletin_v2.cgi.

Научные статьи, посвящённые гриппу свиней (в том числе А/Н1N1), ставшие доступными за последнюю неделю (По данным

информационной базы Scopus):

№ п/п

Автор НазваниеГод

публикации

Ссылка

1. Rungrotmongkol, T., Intharathep, P., Malaisree, M., Nunthaboot, N., Kaiyawet, N., Sompornpisut, P., Payungporn, S., Poovorawan, Y., Hannong-bua, S.

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus

(2009) Biochemical and Bio-physical Research Communications, 385 (3), pp. 390-394.

2. Pan, C., Wang, G., Liao, M., Zhang, G.-H., Jiang, S.

High genetic and antigenic sim-ilarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: A possible immune pressure-driven cross-species transmis-sion


3. Richards, K.A., Chaves, F.A., Sant, A.J.

Infection of HLA-DR1 trans-genic mice with a human isolate

(2009) Journal of virology, 83 (13), pp. 6566-

http://www.scopus.com/

http://www.eiss.org/cgi-files/bulletin_v2.cgi

http://www.rospotrebnadzor.ru/documents/letters/2778/

http://www.who.int/csr/resources/publications/swineflu/ru/index.html

http://www.who.int/csr/resources/publications/swineflu/en/index.html



http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5823a2.htm



of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) in-fluenza virus.

6577.

4. Hurt, A.C., Ernest, J., Deng, Y.-M., Iannello, P., Besselaar, T.G., Birch, C., Buchy, P., Chittagan-pitch, M., Chiu, S.-C., Dwyer, D., Guigon, A., Harrower, B., Kei, I.P., Kok, T., Lin, C., Mc-Phie, K., Mohd, A., Olveda, R., Panayotou, T., Rawlinson, W., Scott, L., Smith, D., D'Souza, H., Komadina, N., Shaw, R., Kelso, A., Barr, I.G.

Emergence and spread of os-eltamivir-resistant A(H1N1) in-fluenza viruses in Oceania, South East Asia and South Africa

(2009) Antiviral Research, 83 (1), pp. 90-93.

5. Kash, J.C. Applications of high-throughput genomics to antiviral research: Evasion of antiviral responses and activation of inflammation during fulminant RNA virus in-fection


6. Ong, C.W., Ho, K.Y., Hsu, L.Y., Lim, A.Y., Fisher, D.A., Tam-byah, P.A.

Reacting to the emergence of swine-origin influenza A H1N1

(2009) The Lancet Infectious Diseases, 9 (7), pp. 397-398.

7. Yamada, K., Ogawa, H., Hara, A., Yoshida, Y., Yonezawa, Y., Karibe, K., Nghia, V.B., Yoshimura, H., Yamamoto, Y., Yamada, M., Nakamura, K., Imai, K.

Mechanism of the antiviral ef-fect of hydroxytyrosol on in-fluenza virus appears to involve morphological change of the virus


8. Hayden, F.G., Howard, W.A., Palkonyay, L., Kieny, M.P.

Report of the 5th meeting on the evaluation of pandemic in-fluenza prototype vaccines in clinical trials. World Health Or-ganization, Geneva, Switzer-land, 12-13 February 2009

(2009) Vaccine, 27 (31), pp. 4079-4089.

9. Camilloni, B., Neri, M., Lepri, E., Iorio, A.M.

Cross-reactive antibodies in middle-aged and elderly volun-teers after MF59-adjuvanted subunit trivalent influenza vac-cine against B viruses of the B/Victoria or B/Yamagata lin-eages

(2009) Vaccine, 27 (31), pp. 4099-4103.

10. Coombes, R. A/H1N1 influenza: questions and answers.

(2009) BMJ (Clinical re-search ed.), 338, .

11. Charatan, F. Mexico City returns to normal-ity, but cases of A/H1N1 reach almost 2000 in US.


12. Migliori, G.B., Sotgiu, G., Lange, C., Macgregor-Skinner, G.

Defining priorities: swine-origin H1N1 and the MDR-TB epi-demic

(2009) The Lancet, 373 (9681), p. 2108.

13. Coker, R. Swine flu. (2009) BMJ (Clinical re-search ed.), 338, .

14. Charatan, F. WHO raises flu pandemic alert to level 5.


15. O'Dowd, A. WHO raises level of alert on flu pandemic.


16. Coombes, R. Chief medical officer warns (2009) BMJ (Clinical re-

against complacency over swine flu.

search ed.), 338, .

17. O'Dowd, A. Health department starts to stockpile masks for clinicians to combat swine flu.


18. Zarocostas, J. Global aid agencies boost sup-port to poorer nations to fight flu threat.


19. Watson, R. Swine flu could come back in more virulent form after sum-mer, European experts say.


20. Yu, H., Zhang, P.-C., Zhou, Y.-J., Li, G.-X., Pan, J., Yan, L.-P., Shi, X.-X., Liu, H.-L., Tong, G.-Z.

Isolation and genetic characteri-zation of avian-like H1N1 and novel ressortant H1N2 influenza viruses from pigs in China

(2009) Biochemical and Bio-physical Research Communications, . Article in Press.

21. Michaelis, M., Doerr, H.W., Cinatl Jr., J.

Novel swine-origin influenza A virus in humans: another pan-demic knocking at the door

(2009) Medical Microbiol-ogy and Immunology, pp. 1-9. Article in Press.

22. Wang, S.-Q., Du, Q.-S., Huang, R.-B., Zhang, D.-W., Chou, K.-C.

Insights from investigating the interaction of oseltamivir (Tam-iflu) with neuraminidase of the 2009 H1N1 swine flu virus

(2009) Biochemical and Bio-physical Research Communications, . Article in Press.

23. Carr, M.J., Gunson, R., Maclean, A., Coughlan, S., Fitzgerald, M., Scully, M., O'Herlihy, B., Ryan, J., O'Flana-gan, D., Connell, J., Carman, W.F., Hall, W.W.

Development of a real-time RT-PCR for the detection of Swine-lineage Influenza A (H1N1) virus infections

(2009) Journal of Clinical Virology, . Article in Press.

24. Malik Peiris, J.S., Poon, L.L.M., Guan, Y.

Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans


25. Zuckerman, M., Carman, B. Diagnosis of swine-lineage in-fluenza A (H1N1) virus infec-tion

(2009) The Lancet, 373 (9681), p. 2107.

26. Li, H., He, Z. Magnetic bead-based DNA hy-bridization assay with chemilu-minescence and chemilumines-cent imaging detection

(2009) Analyst, 134 (4), pp. 800-804.

27. Meijer, A., Beerens, A., Claas, E., Hermans, M., de Jong, A., Molenkamp, R., Niesters, H., Overduin, P., Rossen, J., Schu-urman, R., Wolffs, P., Fouchier, R., Osterhaus, A., Schutten, M., Koopmans, M.

Preparing the outbreak assis-tance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant


28. Ginocchio, C.C., Zhang, F., Manji, R., Arora, S., Bornfre-und, M., Falk, L., Lotlikar, M., Kowerska, M., Becker, G., Ko-rologos, D., de Geronimo, M., Crawford, J.M.

Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City out-break


29. Gatherer, D. The 2009 H1N1 influenza out-break in its historical context


30. Chan, K.H., Lai, S.T., Poon, L.L.M., Guan, Y., Yuen, K.Y., Peiris, J.S.M.

Analytical sensitivity of rapid influenza antigen detection tests for swine-origin influenza virus (H1N1)


31. Human infection with new in- (2009) Relevé épidémi-

fluenza A (H1N1) virus: clinical observations from a school-as-sociated outbreak in Kobe, Japan, May 2009.

ologique hebdo-madaire / Section d'hygiène du Secré-tariat de la Société des Nations = Weekly epidemiological record / Health Sec-tion of the Secretariat of the League of Na-tions, 84 (24), pp. 237-244.

32. Lay, M., Callejo, B., Chang, S., Hong, D.K., Lewis, D.B., Car-roll, T.D., Matzinger, S., Fritts, L., Miller, C.J., Warner, J.F., Liang, L., Fairman, J.

Cationic lipid/DNA complexes (JVRS-100) combined with in-fluenza vaccine (Fluzone®) in-creases antibody response, cel-lular immunity, and antigeni-cally drifted protection

(2009) Vaccine, 27 (29), pp. 3811-3820.

33. Gostin, L.O. Influenza A(H1N1) and pan-demic preparedness under the rule of international law.

(2009) JAMA : the journal of the American Medical Association, 301 (22), pp. 2376-2378.

34. Soundararajan, V., Tharakara-man, K., Raman, R., Raguram, S., Shriver, Z., Sasisekharan, V., Sasisekharan, R.

Extrapolating from sequencethe 2009 H1N1 'swine' influenza virus

(2009) Nature Biotechnol-ogy, 27 (6), pp. 510-513.

35. Sim, F., Mackie, P. Pandemic or no pandemic: Emergence of swine influenza A (H1N1) in 2009

(2009) Public Health, 123 (6), pp. 405-406.

36. Mossad, S.B. The resurgence of swine-origin influenza A (H1N1).

(2009) Cleveland Clinic jour-nal of medicine, 76 (6), pp. 337-343.

37. Shetty, P. Preparation for a pandemic: in-fluenza A H1N1.

(2009) The Lancet infectious diseases, 9 (6), pp. 339-340.

38. Cheng, P.K.C., Leung, T.W.C., Ho, E.C.M., Leung, P.C.K., Ng, A.Y.Y., Lai, M.Y.Y., Lim, W.W.L.

Oseltamivir-and amantadine-re-sistant influenza viruses A (H1N1)

(2009) Emerging Infectious Diseases, 15 (6), pp. 966-968.

39. Awadalla, H.I., El-Kholy, N.F., Barakat, A.B.

Trends of influenza infection in Egypt during two consecutive seasons

(2009) Journal of Public Health, 17 (3), pp. 195-203.

40. Löscher, T., Bogner, J.R. Infectiology and tropical medicine 2009 [Infektiologie und Tropenmedizin 2009.]

(2009) Deutsche medizinis-che Wochenschrift (1946), 134 (25-26), pp. 1343-1348.

41. Allgaier, S., Taylor, R.D., Brud-naya, Y., Jacobson, D.J., Cam-bareri, E., Stuart, W.D.

Vaccine production in Neu-rospora crassa

(2009) Biologicals, 37 (3), pp. 128-132.

42. Perez, J.T., Pham, A.M., Lorini, M.H., Chua, M.A., Steel, J., Tenoever, B.R.

MicroRNA-mediated species-specific attenuation of influenza A virus

(2009) Nature Biotechnol-ogy, 27 (6), pp. 572-576.

43. Uhlendorff, J., Matrosovich, T., Klenk, H.-D., Matrosovich, M.

Functional significance of the hemadsorption activity of in-fluenza virus neuraminidase and its alteration in pandemic viruses

(2009) Archives of Virology, 154 (6), pp. 945-957.

44. Chang, S., Warner, J., Liang, L., Fairman, J.

A novel vaccine adjuvant for re-combinant flu antigens

(2009) Biologicals, 37 (3), pp. 141-147.

45. Loeffen, W.L.A., Hunneman, W.A., Quak, J., Verheijden,

Population dynamics of swine influenza virus in farrow-to-fin-

(2009) Veterinary Microbiol-ogy, 137 (1-2), pp.

J.H.M., Stegeman, J.A. ish and specialised finishing herds in the Netherlands

45-50.

46. Vincent, A.L., Swenson, S.L., Lager, K.M., Gauger, P.C., Loiacono, C., Zhang, Y.

Characterization of an influenza A virus isolated from pigs dur-ing an outbreak of respiratory disease in swine and people dur-ing a county fair in the United States

(2009) Veterinary Microbiol-ogy, 137 (1-2), pp. 51-59.

47. Gaeta, G.B., Pariani, E., Amen-dola, A., Brancaccio, G., Cuomo, G., Stornaiuolo, G., Zappa, A., Zanetti, A.

Influenza vaccination in patients with cirrhosis and in liver trans-plant recipients

(2009) Vaccine, 27 (25-26), pp. 3373-3375.

48. Wong, J.P., Christopher, M.E., Viswanathan, S., Karpoff, N., Dai, X., Das, D., Sun, L.Q., Wang, M., Salazar, A.M.

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

(2009) Vaccine, 27 (25-26), pp. 3481-3483.

49. Barnard, D.L. Animal models for the study of influenza pathogenesis and ther-apy

(2009) Antiviral Research, 82 (2), pp. A110-A122.

50. van Gisbergen, K.P., van Olffen, R.W., van Beek, J., van der Sluijs, K.F., Arens, R., Nolte, M.A., van Lier, R.A.

Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation.

(2009) Journal of immunol-ogy (Baltimore, Md. : 1950), 182 (9), pp. 5352-5362.

Власти Индонезии обязали всех туристов носить маскиВласти Индонезии сделали ношение марлевых повязок обязательным для всех туристов, прибывающих из стран с неблагополучной обстановкой по гриппу H1N1, сообщает Bernama (http://www.bernama.com/bernama/v5/general.php).Как заявила министр здравоохранения Индонезии Сити Фадила Супари (Siti Fadilah Supari), запас марлевых повязок будет создан во всех пунктах прибытия иностранцев. Сообщается, что средства индивидуальной защиты будут предоставляться бесплатно.Кроме того, всем приезжим предложат заполнить специальные декларации о состоянии здоровья, которые будут сохраняться в течение семи дней инкубационного периода болезни или всего времени пребывания туриста в стране. Специалисты также будут контролировать температуру тела всех прибывающих в Индонезию: как туристов, так и ее жителей.По данным министерства здравоохранения Индонезии, лабораторные исследования подтвердили наличие вируса гриппа H1N1 у восьми человек. Четверо из них являются гражданами Индонезии, другая половина – приезжие из Австралии. Одни из заразившихся уже выписан из больницы.

Ситуация по гриппу А H5N1-подтипа за период 29 июня – 6 июля 2009 г.

Грипп А H5N1-подтипа у человекаПо данным ВОЗ на 06.07.2009 общее количество подтверждённых

случаев заболевания, вызванного вирусом гриппа А H5N1-подтипа, составляет 436, из них закончилось летальным исходом по-прежнему 262 (60,1%). За последнюю неделю ВОЗ подтвердила ещё три случая заболевания человека в Египте. Сообщение о последнем подтверждённом случае датируется 01.07.2009. Таким образом, в 2009 году случаи заболевания гриппом птиц были зарегистрированы в Китае, Вьетнаме, Египте и Индонезии, количество

http://www.who.int/csr/don/2009_07_01/ru/index.html

http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_07_01/en/index.html

http://www.who.int/csr/disease/avian_influenza/en/

http://www.bernama.com/bernama/v5/general.php

http://www.bernama.com/bernama/v5/general.php

подтверждённых случаев заболевания гриппом птиц в 2009 году достигло 45, из которых 15 (33,3%) закончились летальным исходом.

1 июля 2009 г. Министерство здравоохранения Египта сообщило о трёх новых подтверждённых случаях инфицирования людей вирусом гриппа A(H5N1).

В первом случае 1 июня 2009 г. у годовалого мальчика из губернаторства Думьят появились симптомы болезни. 2 июня ребенок был госпитализирован и стал получать озельтамивир. Пациент выздоровел и 9 июня был выписан из больницы.

Во втором случае 5 июня 2009 г. у четырёхлетней девочки из губернаторства Дакахлия появились симптомы болезни. 6 июня девочка была госпитализирована и стала получать озельтамивир. Пациентка выздоровела и 14 июня была выписана из больницы.

В третьем случае 15 июня 2009 г. у годовалого мальчика из района Калеен, губернаторство Кафр-эш-Шейх, появились симптомы болезни. 16 июня 2009 г. он был госпитализирован в инфекционную больницу Кафр-эш-Шейха, где стал получать озельтамивир. Ребёнок находится в стабильном состоянии.

В результате расследований источников инфекции установлено, что во всех трёх случаях дети имели тесные контакты с мёртвыми и/или больными домашними птицами.

Случаи заболевания подтверждены Центральными лабораториями общественного здравоохранения Египта.

Из 81 случая заболевания, подтверждённого на сегодняшний день в Египте, 27 (33,3%) закончились смертельным исходом.

Грипп А H5N1- подтипа у птицПо данным Международного эпизоотического бюро и Международного

общества специалистов по инфекционным болезням ( ISID ) за период 29 июня – 6 июля 2009 г. новых сообщений о вспышках гриппа, вызванного вирусом гриппа А H5N1-подтипа, не поступало.

ПубликацииПо данным информационной базы Scopus за последнюю неделю стали доступны в интернет или опубликованы следующие научные статьи, посвящённые изучению гриппа птиц:

№ п/п



Ссылка

1. Clements, A.C.A., Pfeif-fer, D.U.

Emerging viral zoonoses: Frameworks for spatial and spatiotemporal risk as-sessment and resource planning

(2009) Veterinary Journal, 182 (1), pp. 21-30.

2. Hutchinson, T.H., Beesley, A., Frickers, P.E., Readman, J.W., Shaw, J.P., Straub, J.O.

Extending the environmental risk as-sessment for oseltamivir (Tamiflu®) under pandemic use conditions to the coastal marine compartment

(2009) Environment Interna-tional, 35 (6), pp. 931-936.

3. Bahgat, M.M., Kutkat, M.A., Nasraa, M.H., Mostafa, A., Webby, R.,

Characterization of an avian influenza virus H5N1 Egyptian isolate

(2009) Journal of Virological Methods, 159 (2), pp. 244-250.

http://www.scopus.com/

http://www.promedmail.org/pls/otn/f?p=2400:10001:1045683738684973

http://www.promedmail.org/pls/otn/f?p=2400:10001:1045683738684973

http://www.oie.int/wahid-prod/public.php?page=weekly_report_index&admin=0

http://www.who.int/csr/don/2009_07_01/ru/index.html

Bahgat, I.M., Ali, M.A.A.

4. Busani, L., Valsecchi, M.G., Rossi, E., Toson, M., Ferrè, N., Pozza, M.D., Marangon, S.

Risk factors for highly pathogenic H7N1 avian influenza virus infection in poultry during the 1999-2000 epi-demic in Italy

(2009) Veterinary Journal, 181 (2), pp. 171-177.

5. Iwami, S., Takeuchi, Y., Liu, X., Nakaoka, S.

A geographical spread of vaccine-re-sistance in avian influenza epidemics

(2009) Journal of Theoretical Biology, 259 (2), pp. 219-228.

6. Wu, R., Zhang, H., Yang, K., Liang, W., Xiong, Z., Liu, Z., Yang, X., Shao, H., Zheng, X., Chen, M., Xu, D.

Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice


7. Wu, Q., Fang, L., Wu, X., Li, B., Luo, R., Yu, Z., Jin, M., Chen, H., Xiao, S.

A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens

(2009) Molecular Immunol-ogy, 46 (11-12), pp. 2210-2217.

8. Lunelli, A., Pugliese, A., Rizzo, C.

Epidemic patch models applied to pandemic influenza: Contact matrix, stochasticity, robustness of predictions

(2009) Mathematical Bio-sciences, 220 (1), pp. 24-33.

9. Poungpair, O., Chaicumpa, W., Kulkeaw, K., Maneewatch, S., Thueng-in, K., Srimanote, P., Tongtawe, P., Songserm, T., Lekcharoensuk, P., Tapchaisri, P.

Human single chain monoclonal anti-body that recognizes matrix protein of heterologous influenza A virus sub-types

(2009) Journal of Virological Methods, 159 (1), pp. 105-111.

10. Rolling, T., Koerner, I., Zimmermann, P., Holz, K., Haller, O., Staeheli, P., Kochs, G.

Adaptive mutations resulting in en-hanced polymerase activity contribute to high virulence of influenza A virus in mice.

(2009) Journal of virology, 83 (13), pp. 6673-6680.

11. Jahangir, A., Ruenphet, S., Ueda, S., Ueno, Y., Shoham, D., Shindo, J., Okamura, M., Nakamura, M., Takehara, K.

Avian influenza and Newcastle dis-ease viruses from northern pintail in Japan: Isolation, characterization and inter-annual comparisons during 2006-2008

(2009) Virus Research, 143 (1), pp. 44-52.

12. Solomon, A.W., Nayagam, S., Pasvol, G.

Recent advances in tropical medicine (2009) Transactions of the Royal Society of Tropical Medicine and Hygiene, 103 (7), pp. 647-652.

13. Bettencourt, L.M.A., Kaiser, D.I., Kaur, J.

Scientific discovery and topological transitions in collaboration networks

(2009) Journal of Informet-rics, 3 (3), pp. 210-221. Cited 3 times.

14. Choi, H.J., Song, J.H., Park, K.S., Kwon, D.H.

Inhibitory effects of quercetin 3-rham-noside on influenza A virus replica-tion

(2009) European Journal of Pharmaceutical Sci-ences, 37 (3-4), pp. 329-333.

15. Forrest, H.L., Khalenkov, A.M., Govorkova, E.A., Kim, J.-K., Del Giudice, G., Webster, R.G.

Single- and multiple-clade influenza A H5N1 vaccines induce cross protec-tion in ferrets

(2009) Vaccine, 27 (31), pp. 4187-4195.

16. Worrall, E.E., Sudaris-man, Priadi, A.

Sialivac: An intranasal homologous inactivated split virus vaccine contain-ing bacterial sialidase for the control of avian influenza in poultry

(2009) Vaccine, 27 (31), pp. 4161-4168.

17. Quintilio, W., Kubrusly, F.S., Iourtov, D., Miyaki, C., Sakauchi, M.A., Lú-cio, F., de Cássia Dias, S., Takata, C.S., Miyaji, E.N., Higashi, H.G., Leite, L.C.C., Raw, I.

Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice

(2009) Vaccine, 27 (31), pp. 4219-4224.

18. Hien, T.T., Ruiz-Palacios, G.M., Hayden, F.G., Far-rar, J.

Patient-oriented pandemic influenza research

(2009) The Lancet, 373 (9681), pp. 2085-2086.

19. Ludwig, S. Targeting cell signalling pathways to fight the flu: Towards a paradigm change in anti-influenza therapy

(2009) Journal of Antimicro-bial Chemotherapy, 64 (1), pp. 1-4.

20. Zhu, X., Ai, S., Chen, Q., Yin, H., Xu, J.

Label-free electrochemical detection of Avian Influenza Virus genotype utilizing multi-walled carbon nan-otubes-cobalt phthalocyanine-PA-MAM nanocomposite modified glassy carbon electrode

(2009) Electrochemistry Communications, . Article in Press.

21. Wu, H., Williams, K., Singh, S.R., Scissum-Gunn, K., Singh, N.K., Teresa, D., Giambrone, J.J.

Integrity of a recombinant hemagglu-tinin protein of an avian influenza virus

(2009) Biotechnology Let-ters, pp. 1-7. Article in Press.

22. Zhirnov, O.P., Vorobjeva, I.V., Saphonova, O.A., Poyarkov, S.V., Ovcharenko, A.V., Anhlan, D., Malyshev, N.A.

Structural and evolutionary character-istics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells


23. Arnon, R., Ben-Yedidia, T.

Preclinical efficacy of a virus-like par-ticle-based vaccine against avian in-fluenza H5N1

(2009) Future Microbiology, 4 (5), pp. 503-505.

24. Maneewatch, S., Thanongsaksrikul, J., Songserm, T., Thueng-In, K., Kulkeaw, K., Thathaisong, U., Sriman-ote, P., Tongtawe, P., Tapchaisri, P., Chaicumpa, W.

Human single-chain antibodies that neutralize homologous and heterolo-gous strains and clades of influenza A virus subtype H5N1.

(2009) Antiviral therapy, 14 (2), pp. 221-230.

25. Jafari, R.A., Ghorban-poor, M., Diarjan, S.H.

Study on immunomodulatory activity of dietary garlic in chickens vacci-nated against avian influenza virus

(2009) International Journal of Poultry Science, 8

(Subtype H9N2 ) (4), pp. 401-403.

26. Wu, R., Chen, Q., Zheng, L., Chen, J., Sui, Z., Guan, Y., Chen, Z.

Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza

(2009) Archives of Virology, pp. 1-8. Article in Press.

27. Li, H., He, Z. Magnetic bead-based DNA hybridiza-tion assay with chemiluminescence and chemiluminescent imaging detec-tion

(2009) Analyst, 134 (4), pp. 800-804.

28. Ascione, A., Capecchi, B., Campitelli, L., Imperi-ale, V., Flego, M., Zam-boni, S., Gellini, M., Al-berini, I., Pittiglio, E., Do-natelli, I., Temperton, N.J., Cianfriglia, M.

Human monoclonal antibodies in sin-gle chain fragment variable format with potent neutralization activity against influenza virus H5N1

(2009) Antiviral Research, . Article in Press.

29. Adam, V., Huska, D., Hubalek, J., Kizek, R.

Easy to use and rapid isolation and de-tection of a viral nucleic acid by using paramagnetic microparticles and car-bon nanotubes-based screen-printed electrodes

(2009) Microfluidics and Nanofluidics, pp. 1-11. Article in Press.

30. Sedlmaier, N., Hoppen-heidt, K., Krist, H., Lehmann, S., Lang, H., Büttner, M.

Generation of avian influenza virus (AIV) contaminated fecal fine particu-late matter (PM2.5): Genome and in-fectivity detection and calculation of immission

(2009) Veterinary Microbiol-ogy, . Article in Press.

31. Liem, N.T., Tung, C.V., Hien, N.D., Hien, T.T., Chau, N.Q., Long, H.T., Hien, N.T., Mai, L.Q., Taylor, W.R.J., Wertheim, H., Farrar, J., Khang, D.D., Horby, P.

Clinical features of human influenza a (H5N1) infection in vietnam: 2004-2006

(2009) Clinical Infectious Diseases, 48 (12), pp. 1639-1646.

32. Lin, C.-H., Hung, C.-H., Hsiao, C.-Y., Lin, H.-C., Ko, F.-H., Yang, Y.-S.

Poly-silicon nanowire field-effect transistor for ultrasensitive and label-free detection of pathogenic avian in-fluenza DNA

(2009) Biosensors and Bio-electronics, 24 (10), pp. 3019-3024.

33. Yang, J., Gebe, J.A., Hus-ton, L., James, E., Tan, V., Yue, B.B., Nepom, G.T., Kwok, W.W.

H5N1 strain-specific Hemagglutinin CD4+ T cell epitopes restricted by HLA DR4

(2009) Vaccine, 27 (29), pp. 3862-3869.

34. D'Ursi, P., Chiappori, F., Merelli, I., Cozzi, P., Rovida, E., Milanesi, L.

Virtual screening pipeline and ligand modelling for H5N1 neuraminidase


35. Strategic Advisory Group of Experts: recommendations on the use of li-censed human H5N1 influenza vac-cines in the interpandemic period.

(2009) Relevé épidémi-ologique hebdo-madaire / Section d'hygiène du Secré-tariat de la Société des Nations = Weekly

epidemiological record / Health Sec-tion of the Secretariat of the League of Na-tions, 84 (24), pp. 244-248.

36. Lee, C., Song, D., Kang, B., Kang, D., Yoo, J., Jung, K., Na, G., Lee, K., Park, B., Oh, J.

A serological survey of avian origin canine H3N2 influenza virus in dogs in Korea


37. Wang, M., Fu, C.-X., Zheng, B.-J.

Antibodies against H5 and H9 avian influenza among poultry workers in China

(2009) New England Journal of Medicine, 360 (24), pp. 2583-2584.

38. Hayden, E.C. Avian influenza aided readiness for swine flu

(2009) Nature, 459 (7248), pp. 756-757.

39. Talaat, K.R., Karron, R.A., Callahan, K.A., Luke, C.J., DiLorenzo, S.C., Chen, G.L., Lami-rande, E.W., Jin, H., Coelingh, K.L., Murphy, B.R., Kemble, G., Sub-barao, K.

A live attenuated H7N3 influenza virus vaccine is well tolerated and im-munogenic in a Phase I trial in healthy adults

(2009) Vaccine, 27 (28), pp. 3744-3753.

40. Earhart, K.C., Elsayed, N.M., Saad, M.D., Gubareva, L.V., Nayel, A., Deyde, V.M., Abdel-sattar, A., Abdelghani, A.S., Boynton, B.R., Mansour, M.M., Essmat, H.M., Klimov, A., Shuck-Lee, D., Monteville, M.R., Tjaden, J.A.

Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt

(2009) Journal of Infection and Public Health, 2 (2), pp. 74-80.

41. Maas, R., Tacken, M., van Zoelen, D., Oei, H.

Dose response effects of avian in-fluenza (H7N7) vaccination of chick-ens: Serology, clinical protection and reduction of virus excretion

(2009) Vaccine, 27 (27), pp. 3592-3597.

42. Busani, L., Toson, M., Stegeman, A., Pozza, M.D., Comin, A., Mulatti, P., Cecchinato, M., Marangon, S.

Vaccination reduced the incidence of outbreaks of low pathogenicity avian influenza in northern Italy

(2009) Vaccine, 27 (27), pp. 3655-3661.

43. van't Hoff, G., Fedose-jeva, R., Mihailescu, L.

Prisons' preparedness for pandemic flu and the ethical issues

(2009) Public Health, 123 (6), pp. 422-425. Cited 2 times.

44. Pfeiffer, J., Pantin-Jack-wood, M., To, T.L., Nguyen, T., Suarez, D.L.

Phylogenetic and biological character-ization of highly pathogenic H5N1 avian influenza viruses (Vietnam 2005) in chickens and ducks

(2009) Virus Research, 142 (1-2), pp. 108-120.

45. Chen, H.-T., Zhang, J., Ma, L.-N., Ma, Y.-P., Ding, Y.-Z., Wang, M.,

Rapid subtyping of H9N2 influenza virus by a triple reverse transcription

(2009) Journal of Virological Methods, 158 (1-2),

Liu, X.-T., Zhang, Y.-G., Liu, Y.-S.

polymerase chain reaction pp. 58-62.

46. Wasilenko, J.L., Sar-mento, L., Pantin-Jack-wood, M.J.

A single substitution in amino acid 184 of the NP protein alters the repli-cation and pathogenicity of H5N1 avian influenza viruses in chickens


47. Alexander, P.E., De, P., Rave, S.

Is H9N2 avian influenza virus a pan-demic potential?

(2009) Canadian Journal of Infectious Diseases and Medical Microbi-ology, 20 (2), pp. e35-e36.

48. Lau, L., Lau, Y., Lau, Y.H.

Prevalence and correlates of influenza vaccination among non-institutional-ized elderly people: An exploratory cross-sectional survey

(2009) International Journal of Nursing Studies, 46 (6), pp. 768-777.

49. Boltz, D.A., Douangngeun, B., Sinthasak, S., Phom-machanh, P., Mi-douangchanh, P., Walker, D., Keating, R., Khalenkov, A.M., Kumar, M., Webster, R.G.

Field assessment of an H5N1 inacti-vated vaccine in chickens and ducks in Lao PDR


50. Little, C.M., Merritt, M., Wentworth, A.

An improvised oxygen supply system for pandemic and disaster use

(2009) Academic Emergency Medicine, 16 (6), pp. 558-563.

51. Radonovich, L.J., Maga-lian, P.D., Hollingsworth, M.K., Baracco, G.

Stockpiling supplies for the next in-fluenza pandemic

(2009) Emerging Infectious Diseases, 15 (6), .

52. Anchun, C., Mingshu, W., Hongyi, X., Dekang, Z., Xinran, L., Haijuen, C., Renyong, J., Miao, Y.

Development and application of a re-verse transcriptase polymerase chain reaction to detect Chinese isolates of duck hepatitis virus type 1 (DOI:10.1016/j.mimet.2009.02.003)

(2009) Journal of Microbio-logical Methods, 77 (3), pp. 332-336.

53. Khan, A.S., Ma, W., Ma, Y., Kumar, A., Williams, D.K., Muller, J., Ma, H., Galvin, T.A.

Proposed algorithm to investigate la-tent and occult viruses in vaccine cell substrates by chemical induction

(2009) Biologicals, 37 (3), pp. 196-201.

54. Doroshenko, A., Halperin, S.A.

Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines)

(2009) Expert Review of Vaccines, 8 (6), pp. 679-688.

55. Ghersi, B.M., Blazes, D.L., Icochea, E., Gonza-lez, R.I., Kochel, T., Tinoco, Y., Sovero, M.M., Lindstrom, S., Shu, B., Klimov, A., Gonzalez, A.E., Montgomery, J.M.

Avian influenza in wild birds, central coast of Peru


56. Brown, J.D., Stallknecht, D.E., Berghaus, R.D., Luttrell, M.P., Velek, K.,

Evaluation of a commercial blocking enzyme-linked immunosorbent assay to detect avian influenza virus anti-

(2009) Clinical and Vaccine Immunology, 16 (6),

Kistler, W., Costa, T., Yabsley, M.J., Swayne, D.

bodies in multiple experimentally in-fected avian species

pp. 824-829.

57. Terrier, O., Essere, B., Yver, M., Barthélémy, M., Bouscambert-Duchamp, M., Kurtz, P., VanMechelen, D., Morfin, F., Billaud, G., Ferraris, O., Lina, B., Rosa-Calatrava, M., Moules, V.

Cold oxygen plasma technology effi-ciency against different airborne respi-ratory viruses

(2009) Journal of Clinical Virology, 45 (2), pp. 119-124.

58. Belser, J.A., Bridges, C.B., Katz, J.M., Tumpey, T.M.

Past, present, and possible future hu-man infection with influenza virus A subtype H7


59. Luo, Q., Huang, H., Zou, W., Dan, H., Guo, X., Zhang, A., Yu, Z., Chen, H., Jin, M.

An indirect sandwich ELISA for the detection of avian influenza H5 sub-type viruses using anti-hemagglutinin protein monoclonal antibody


60. Müller, I., Pinto, E., San-tibáñez, M.C., Celedón, M.O., Valenzuela, P.D.T.

Isolation and characterization of the equine influenza virus causing the 2006 outbreak in Chile


61. Song, M.-S., Oh, T.-K., Pascua, P.N.Q., Moon, H.-J., Lee, J.H., Baek, Y.H., Woo, K.-J., Yoon, Y., Sung, M.-H., Poo, H., Kim, C.-J., Choi, Y.K.

Investigation of the biological indica-tor for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and fer-rets

(2009) Vaccine, 27 (24), pp. 3145-3152.

62. Kwon, J.-S., Kim, M.-C., Jeong, O.-M., Kang, H.-M., Song, C.-S., Kwon, J.-H., Lee, Y.-J.

Novel use of a N2-specific enzyme-linked immunosorbent assay for dif-ferentiation of infected from vacci-nated animals (DIVA)-based identifi-cation of avian influenza

(2009) Vaccine, 27 (24), pp. 3189-3194.

63. Patel, A., Tran, K., Gray, M., Li, Y., Ao, Z., Yao, X., Kobasa, D., Kobinger, G.P.

Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses

(2009) Vaccine, 27 (23), pp. 3083-3089.

64. Ikeno, D., Kimachi, K., Kudo, Y., Goto, S., Ita-mura, S., Odagiri, T., Tashiro, M., Kino, Y.

A prime-boost vaccination of mice with heterologous H5N1 strains

(2009) Vaccine, 27 (23), pp. 3121-3125.

65. Xing, Z., Cardona, C.J., Adams, S., Yang, Z., Li, J., Perez, D., Woolcock, P.R.

Differential regulation of antiviral and proinflammatory cytokines and sup-pression of Fas-mediated apoptosis by NS1 of H9N2 avian influenza virus in chicken macrophages.

(2009) The Journal of gen-eral virology, 90 (Pt 5), pp. 1109-1118.

66. Fan, S., Gao, Y., Shinya, K., Li, C.K., Li, Y., Shi, J., Jiang, Y., Suo, Y., Tong, T., Zhong, G., Song, J., Zhang, Y., Tian, G., Guan, Y., Xu, X.-N.,

Immunogenicity and protective effi-cacy of a live attenuated H5N1 vac-cine in nonhuman primates

(2009) PLoS Pathogens, 5 (5), art. no. e1000409, .

Bu, Z., Kawaoka, Y., Chen, H.

67. Scull, M.A., Gillim-Ross, L., Santos, C., Roberts, K.L., Bordonali, E., Sub-barao, K., Barclay, W.S., Pickles, R.J.

Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways


68. Brown, L.E., Kelso, A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes

(2009) Immunology and Cell Biology, 87 (4), pp. 300-308.

69. Reed, N.G., Wengraitis, S., Sliney, D.H.

Intercomparison of instruments used for safety and performance measure-ments of ultraviolet germicidal irradia-tion lamps.

(2009) Journal of occupa-tional and environ-mental hygiene, 6 (5), pp. 289-297.

70. Goodman, A.G., Fornek, J.L., Medigeshi, G.R., Perrone, L.A., Peng, X., Dyer, M.D., Proll, S.C., Knoblaugh, S.E., Carter, V.S., Korth, M.J., Nelson, J.A., Tumpey, T.M., Katze, M.G.

p58IPK: A novel "CIHD" member of the host innate defense response against pathogenic virus infection


71. Yuan, P., Bartlam, M., Lou, Z., Chen, S., Zhou, J., He, X., Lv, Z., Ge, R., Li, X., Deng, T., Fodor, E., Rao, Z., Liu, Y.

Crystal structure of an avian influenza polymerase PA N reveals an endonu-clease active site

(2009) Nature, 458 (7240), pp. 909-913. Cited 2 times.

72. Dias, A., Bouvier, D., Crépin, T., McCarthy, A.A., Hart, D.J., Baudin, F., Cusack, S., Ruigrok, R.W.H.

The cap-snatching endonuclease of in-fluenza virus polymerase resides in the PA subunit

(2009) Nature, 458 (7240), pp. 914-918. Cited 3 times.

73. Konstadakopulos, D. Cooling the earth? The changing pri-orities of EU - Asia technology coop-eration

(2009) Asia Europe Journal, 7 (2), pp. 345-366.

74. Shestopalova, L.V., Shku-rupiy, V.A., Sharkova, T.V., Shestopalov, A.M.

Morphological changes in bird viscera in experimental infection by highly pathogenic H5N1 avian influenza virus

(2008) Bulletin of Experi-mental Biology and Medicine, 146 (6), pp. 770-773.

75. Evseenko, V.A., Sharshov, K.A., Bukin, E.K., Zaykovskaya, A.V., Ternovoy, V.A., Ignatyev, G.M., Shestopalov, A.M., Netesov, S.V., Shkurupiy, V.A., Drozdov, I.G.

Pathogenesis of infectious disease of mice caused by H5N1 avian influenza virus

(2008) Bulletin of Experi-mental Biology and Medicine, 146 (6), pp. 766-769.

№ п/п



Ссылка

1. Aamir, U.B., Naeem, K., Zoonotic potential of highly (2009) Virology, . Article in

Ahmed, Z., Obert, C.A., Franks, J., Krauss, S., Seiler, P., Webster, R.G.

pathogenic avian H7N3 in-fluenza viruses from Pakistan

Press.

2. Jewell, C.P., Kypraios, T., Christley, R.M., Roberts, G.O.

A novel approach to real-time risk prediction for emerging infectious diseases: A case study in Avian Influenza H5N1

(2009) Preventive Veterinary Medicine, . Article in Press.

3. Damery, S., Wilson, S., Draper, H., Gratus, C., Greenfield, S., Ives, J., Parry, J., Petts, J., Sorell, T.

Will the NHS continue to function in an influenza pan-demic? a survey of healthcare workers in the West Mid-lands, UK

(2009) BMC Public Health, 9, art. no. 142, .

4. Wikramaratna, P.S., Gupta, S.

Influenza outbreaks (2009) Cellular Microbiology, 11 (7), pp. 1016-1024.

5. Szeleczky, Z., Dán, A., Ursu, K., Ivanics, E., Kiss, I., Erdélyi, K., Belák, S., Muller, C.P., Brown, I.H., Bálint, A.

Four different sublineages of highly pathogenic avian in-fluenza H5N1 introduced in Hungary in 2006-2007

(2009) Veterinary Microbiol-ogy, . Article in Press.

6. Hsieh, J.-L., Huang, C.-Y., Sun, C.-T., Tsai, Y.-S., Gloria, Y.-M.K.

Learning to build network-oriented epidemic simulation models in epidemiology edu-cation

(2009) International Journal of Simulation and Process Modelling, 5 (1), pp. 31-41.

7. Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclu-sions and recommendations.

(2009) Relevé épidémi-ologique hebdo-madaire / Section d'hy-giène du Secrétariat de la Société des Nations = Weekly epidemiologi-cal record / Health Sec-tion of the Secretariat of the League of Nations, 84 (23), pp. 220-236.

8. Stannard, D. Pandemic Influenza: Impact on Perianesthesia Nursing Ar-eas

(2009) Journal of Perianesthe-sia Nursing, 24 (3), pp. 137-140.

9. Newman, S.H., Iverson, S.A., Takekawa, J.Y., Gilbert, M., Prosser, D.J., Batbayar, N., Nat-sagdorj, T., Douglas, D.C.

Migration of whooper swans and outbreaks of highly path-ogenic avian influenza H5N1 virus in eastern asia

(2009) PLoS ONE, 4 (5), art. no. e5729, .

10. Ho, H.-T., Qian, H.-L., He, F., Meng, T., Szy-porta, M., Prabhu, N., Prabakaran, M., Chan, K.-P., Kwang, J.

Rapid detection of H5N1 sub-type influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- And N1-specific monoclonal antibodies

(2009) Clinical and Vaccine Immunology, 16 (5), pp. 726-732.

11. Brigantic, R.T., Malone, J.D., Muller, G.A., Lee, R., Kulesz, J., Delp, W.W.

Simulation to assess the effi-cacy of US airport entry screening of passengers for pandemic influenza

(2009) International Journal of Risk Assessment and Management, 12 (2-4), pp. 290-310.

12. Wu, J.T., Leung, G.M., Lipsitch, M., Cooper,

Hedging against antiviral re-sistance during the next in-

(2009) PLoS Medicine, 6 (5), art. no. e1000085, .

B.S., Riley, S. fluenza pandemic using small stockpiles of an alternative chemotherapy

13. Seller, K. Education is the key to man-aging a flu pandemic

(2009) Occupational Health, 61 (5), p. 17.

14. Merget, R., Sander, I., Ewig, S., Sennekamp, J., Bruening, T.

Consort hypersensitivity pneumonitis

(2009) European Respiratory Journal, 33 (5), pp. 1223-1225.

15. Atlas, R.M., Clover, R.D., McKinney, W.P.

Enhancing biosecurity through early recognition and reporting of public health risks: meeting the challenges of the revised international health regulations


16. Lee, E.K., Smalley, H.K., Zhang, Y., Pietz, F., Benecke, B.

Facility location and multi-modality mass dispensing strategies and emergency re-sponse for biodefence and in-fectious disease outbreaks


17. Harris, M., Powell, J. Societal stability, public health and primary care as three pillars of defence in biosecurity


18. Abubakar, M.B., Aini, I., Omar, A.R., Hair Bejo, M.

Avian infuenza: Global as-sessment of potential pan-demic of the twenty first cen-tury

(2009) Journal of Food, Agri-culture and Environ-ment, 7 (2), pp. 10-19.

19. Ohkusa, Y., Sugawara, T.

Simulation model of pan-demic influenza in the whole of Japan.

(2009) Japanese journal of in-fectious diseases, 62 (2), pp. 98-106.

20. Bolotin, S., De Lima, C., Choi, K.-W., Lombos, E., Burton, L., Mazzulli, T., Drews, S.J.

Validation of the TaqMan in-fluenza A detection kit and a rapid automated total nucleic acid extraction method to de-tect influenza A virus in na-sopharyngeal specimens

(2009) Annals of Clinical and Laboratory Science, 39 (2), pp. 155-159.

21. Cooper, D.L., Verlander, N.Q., Elliot, A.J., Joseph, C.A., Smith, G.E.

Can syndromic thresholds provide early warning of na-tional influenza outbreaks?

(2009) Journal of public health (Oxford, England), 31 (1), pp. 17-25.

22. Hao, S.M., Li, Q., Wang, C.Y., Wang, H.L., Yang, S.T., Xia, X.Z.

Cloning and expression of single-chain Fv antibodies against H5N1 Avian in-fluenza virus hemagglutinin

(2009) Bing du xue bao = Chi-nese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui], 25 (1), pp. 63-67.

23. Ambrose, C.S., Luke, C., Coelingh, K.

Current status of live attenu-ated influenza vaccine in the United States for seasonal and pandemic influenza.

(2008) Influenza and other res-piratory viruses, 2 (6), pp. 193-202.

24. Qiu, Y.Z., Yin, W.D. Safety and immunogenicity of Sinovac's prototype pan-demic influenza H5N1 vac-cines: a review on clinical tri-als.


25. Banzhoff, A., Pellegrini, MF59-adjuvanted vaccines (2008) Influenza and other res-

M., Del Giudice, G., Fra-gapane, E., Groth, N., Podda, A.

for seasonal and pandemic in-fluenza prophylaxis.

piratory viruses, 2 (6), pp. 243-249.

26. Tada, Y. Characterization of a whole, inactivated influenza (H5N1) vaccine.


27. Baras, B., Bouveret, N., Devaster, J.M., Fries, L., Gillard, P., Sänger, R., Hanon, E.

A vaccine manufacturer's ap-proach to address medical needs related to seasonal and pandemic influenza viruses.


28. Vajo, Z., Kosa, L., Szil-vasy, I., Pauliny, Z., Bartha, K., Visontay, I., Jankovics, M., Kis, A., Jankovics, I.

Yearly licensing studies from 1997 to 2007 of the inacti-vated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed coun-tries?


29. Rudenko, L., Desheva, J., Korovkin, S., Mironov, A., Rekstin, A., Grigorieva, E., Don-ina, S., Gambaryan, A., Katlinsky, A.

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).


30. Saville, M., Marsh, G., Hoffenbach, A.

Improving seasonal and pan-demic influenza vaccines.


31. Hampson, A.W., Wood, J.

Recent developments in sea-sonal and pandemic influenza vaccines.


32. Chen, X., Smith, G.J., Zhou, B., Qiu, C., Wu, W.L., Li, Y., Lu, P., Duan, L., Liu, S., Yuan, J., Yang, G., Wang, H., Cheng, J., Jiang, H., Peiris, J.S., Chen, H., Yuen, K.Y., Zhong, N., Guan, Y.

Avian influenza A (H5N1) infection in a patient in China, 2006.

(2007) Influenza and other res-piratory viruses, 1 (5-6), pp. 207-213.

33. Daum, L.T., Canas, L.C., Arulanandam, B.P., Niemeyer, D., Valdes, J.J., Chambers, J.P.

Real-time RT-PCR assays for type and subtype detection of influenza A and B viruses.


34. Wood, J.S., Robertson, J.S.

Reference viruses for sea-sonal and pandemic influenza vaccine preparation.

(2007) Influenza and other res-piratory viruses, 1 (1), pp. 5-9. Cited 6 times.

Вспышка гриппа К-9 в центральном Нью-Джерси (США)http://examiner.gmnews.com/news/2009/0702/front_page/030.html

В районе Миллстоун зарегистрирована вспышка гриппа собак. В течение нескольких последних недель в ветеринарной клинике NorthStar VETS, расположенной в Клаксберге, наблюдалось повышенное количество обращений по поводу этого вируса. В настоящее время зарегистрировано 9 случаев

http://examiner.gmnews.com/news/2009/0702/front_page/030.html

инфицирования собак, и, учитывая высокую контагиозность этого вируса, можно ожидать увеличение количества обращений. Грипп собак не контагиозен для людей, кошек и других видов животных, хотя люди могут переносить этот вирус в носовых проходах и передавать его собакам дома.

Грипп собак следует рассматривать как серьёзное заболевание; смертность инфицированных животных составляет 100%. Однако при быстрой и точной диагностике и правильном лечении животных смертность может быть снижена до 1-5%.

Подробности - на нашем сайте www . vector . nsc . ru При использовании материалов рассылки и материалов сайта

ссылка на ФГУН ГНЦ ВБ «Вектор» Роспотребнадзора обязательнаМы будем рады получить Ваши отклики, замечания, предложения

по адресу info @ vector . nsc . ru .С уважением,

ведущая рассылки Кихтенко Наталия Владимировна,

начальник отдела пресс-службы и поддержки Интернет-сайта Центра

mailto:[email protected]

http://www.vector.nsc.ru/

56.doc

Documents